Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs ZETA (ZEX) Price & Performance

InjectiveTrade
ZETATrade

Price performance (Past 24H)

Key statistics

Injective vs ZETA — how do they compare? Injective trades at Rp92,735 (market cap Rp9,29T, Rp1,82T 24h volume), while ZETA trades at Rp178.79 (market cap Rp34,62M, Rp6,54M 24h volume). The key difference: Injective is far larger — about 268342× ZETA's market cap, and ZETA's supply is capped (187,8M / 1B ZEX (19%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and ZETA for 8 Days on average.

INJZEX
Market Cap
Rp9,29TRp34,62M
Volume (24h)
Rp1,82TRp6,54M
Circulating Supply
100M INJ187,8M / 1B ZEX (19%)
Typical Hold Time
36 Days8 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

ZETA

ZEX token shows limited market activity with a modest market cap of Rp34.62 million and only 19% of max supply in circulation. The asset exhibits low trading volume and network activity, with an average hold time of 8 days suggesting short-term speculative interest. Current technical positioning indicates minimal price movement and thin liquidity across exchanges.

Overall outlook remains cautious due to limited adoption and ecosystem development. Key opportunities exist if protocol utility expands, while major risks include extreme volatility from low liquidity and regulatory uncertainty in the crypto space. Investors should monitor for increased network activity and exchange listings.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
ZEX

No sentiment data available yet.

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About ZETA

Zeta Markets is developing the fastest, simplest, and most secure decentralized exchange (DEX) for perpetual contracts on the market. By utilizing the advanced scalability of the Solana blockchain, Zeta provides features and performance comparable to centralized exchanges (CEX), while maintaining the self-custodial nature and transparency inherent to DEXs. ZEX is the governance token of the Zeta platform, granting holders governance rights as well as a share in ongoing trading and staking incentives. This structure is designed to align the long-term interests of the protocol with those of the community.

Read more on ZEX